WRF
CLB icon

Waddell & Reed Financial’s Core Laboratories CLB Stock Holding History

Waddell & Reed Financial’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-284,871
Closed -$10.7M – 442
2019
Q4 		$10.7M Sell
284,871
-96,055
-25% -$4.32M 0.03% 385
2019
Q3 		$17.8M Buy
380,926
+29,069
+8% +$1.35M 0.05% 351
2019
Q2 		$18.4M Sell
351,857
-34,723
-9% -$2.04M 0.05% 366
2019
Q1 		$26.6M Buy
386,580
+112,271
+41% +$7.53M 0.07% 308
2018
Q4 		$16.4M Sell
274,309
-7,791
-3% -$672K 0.05% 346
2018
Q3 		$32.7M Sell
282,100
-230,302
-45% -$26M 0.07% 281
2018
Q2 		$64.7M Sell
512,402
-42,780
-8% -$5.21M 0.15% 161
2018
Q1 		$60.1M Buy
555,182
+33,817
+6% +$3.74M 0.14% 172
2017
Q4 		$57.1M Buy
521,365
+199,914
+62% +$20M 0.13% 190
2017
Q3 		$31.7M Sell
321,451
-18,600
-5% -$1.8M 0.07% 283
2017
Q2 		$34.4M Sell
340,051
-2,750
-0.8% -$296K 0.08% 285
2017
Q1 		$39.6M Buy
342,801
+74,181
+28% +$8.62M 0.08% 250
2016
Q4 		$32.2M Buy
268,620
+9,470
+4% +$1.05M 0.07% 276
2016
Q3 		$29.1M Sell
259,150
-26,050
-9% -$3M 0.06% 270
2016
Q2 		$35.3M Buy
285,200
+36,870
+15% +$4.45M 0.07% 248
2016
Q1 		$27.9M Buy
248,330
+25,820
+12% +$2.68M 0.05% 258
2015
Q4 		$24.2M Buy
222,510
+69,410
+45% +$7.95M 0.04% 291
2015
Q3 		$15.3M Buy
153,100
+10,000
+7% +$1.09M 0.03% 346
2015
Q2 		$16.3M Buy
143,100
+23,800
+20% +$2.89M 0.02% 371
2015
Q1 		$12.5M Sell
119,300
-101,100
-46% -$10.8M 0.02% 405
2014
Q4 		$26.5M Sell
220,400
-75,125
-25% -$9.87M 0.04% 301
2014
Q3 		$43.3M Sell
295,525
-50,809
-15% -$7.84M 0.06% 237
2014
Q2 		$57.9M Sell
346,334
-24,538
-7% -$4.37M 0.08% 225
2014
Q1 		$73.6M Buy
370,872
+66,218
+22% +$12.5M 0.11% 185
2013
Q4 		$58.2M Sell
304,654
-17,200
-5% -$3.2M 0.09% 207
2013
Q3 		$54.5M Sell
321,854
-221,292
-41% -$34.3M 0.1% 196
2013
Q2 		$82.4M Buy
+543,146
New +$77M 0.17% 140

Other funds holding CLB

VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
MPI
Mairs & Power Inc St Paul, Minnesota $9.79B AUM 20.6% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Waddell & Reed Financial's CLB Position: Q1 2020 in Review

Waddell & Reed Financial sold out of Core Laboratories (CLB) in Q1 2020, closing a stake of 284,871 shares — an estimated $10.7M sold.

Waddell & Reed Financial first reported a position in CLB in Q2 2013 and held it in 27 quarters. The position peaked at $82.4M in Q2 2013. 207 funds tracked by Wall St. Rank hold CLB as of Q1 2020.

  • Waddell & Reed Financial reported no remaining Core Laboratories position as of Q1 2020 after selling out during the quarter.
  • Waddell & Reed Financial sold 284,871 Core Laboratories shares in Q1 2020, an estimated $10.7M.
  • Waddell & Reed Financial first reported a position in Core Laboratories in Q2 2013 and held it in 27 quarters.
  • Waddell & Reed Financial's Core Laboratories position peaked at $82.4M in Q2 2013.
  • 207 funds tracked by Wall St. Rank held Core Laboratories as of Q1 2020.

Based on Waddell & Reed Financial's 13F filing for Q1 2020, filed 15 May 2020.